Further evidence for POMK as candidate gene for WWS with meningoencephalocele.

Alpha-dystroglycanopathy Congenital muscular dystrophy Meningoencephalocele POMK Protein O-mannose kinase Walker-Warburg syndrome

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
09 09 2020
Historique:
received: 18 05 2020
accepted: 29 06 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 22 6 2021
Statut: epublish

Résumé

Walker-Warburg syndrome (WWS) is a rare form of alpha-dystroglycanopathy characterized by muscular dystrophy and severe malformations of the CNS and eyes. Bi-allelic pathogenic variants in POMK are the cause of a broad spectrum of alpha-dystroglycanopathies. POMK encodes protein-O-mannose kinase, which is required for proper glycosylation and function of the dystroglycan complex and is crucial for extracellular matrix composition. Here, we report on male monozygotic twins with severe CNS malformations (hydrocephalus, cortical malformation, hypoplastic cerebellum, and most prominently occipital meningocele), eye malformations and highly elevated creatine kinase, indicating the clinical diagnosis of a congenital muscular dystrophy (alpha-dystroglycanopathy). Both twins were found to harbor a homozygous nonsense mutation c.640C>T, p.214* in POMK, confirming the clinical diagnosis and supporting the concept that POMK mutations can be causative of WWS. Our combined data suggest a more important role for POMK in the pathogenesis of meningoencephalocele. Only eight different pathogenic POMK variants have been published so far, detected in eight families; only five showed the severe WWS phenotype, suggesting that POMK-associated WWS is an extremely rare disease. We expand the phenotypic and mutational spectrum of POMK-associated WWS and provide evidence of the broad phenotypic variability of POMK-associated disease.

Sections du résumé

BACKGROUND
Walker-Warburg syndrome (WWS) is a rare form of alpha-dystroglycanopathy characterized by muscular dystrophy and severe malformations of the CNS and eyes. Bi-allelic pathogenic variants in POMK are the cause of a broad spectrum of alpha-dystroglycanopathies. POMK encodes protein-O-mannose kinase, which is required for proper glycosylation and function of the dystroglycan complex and is crucial for extracellular matrix composition.
RESULTS
Here, we report on male monozygotic twins with severe CNS malformations (hydrocephalus, cortical malformation, hypoplastic cerebellum, and most prominently occipital meningocele), eye malformations and highly elevated creatine kinase, indicating the clinical diagnosis of a congenital muscular dystrophy (alpha-dystroglycanopathy). Both twins were found to harbor a homozygous nonsense mutation c.640C>T, p.214* in POMK, confirming the clinical diagnosis and supporting the concept that POMK mutations can be causative of WWS.
CONCLUSION
Our combined data suggest a more important role for POMK in the pathogenesis of meningoencephalocele. Only eight different pathogenic POMK variants have been published so far, detected in eight families; only five showed the severe WWS phenotype, suggesting that POMK-associated WWS is an extremely rare disease. We expand the phenotypic and mutational spectrum of POMK-associated WWS and provide evidence of the broad phenotypic variability of POMK-associated disease.

Identifiants

pubmed: 32907597
doi: 10.1186/s13023-020-01454-0
pii: 10.1186/s13023-020-01454-0
pmc: PMC7488248
doi:

Substances chimiques

POMK protein, human EC 2.7.-
Protein Kinases EC 2.7.-

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

242

Références

Saudi Med J. 2014 Dec;35 Suppl 1:S49-56
pubmed: 25551112
J Med Genet. 2014 Apr;51(4):275-82
pubmed: 24556084
Hum Mol Genet. 2014 Nov 1;23(21):5781-92
pubmed: 24925318
Nature. 2002 Jul 25;418(6896):422-5
pubmed: 12140559
Science. 2013 Apr 26;340(6131):479-83
pubmed: 23519211
Genes Cells. 2017 Apr;22(4):348-359
pubmed: 28251761
Am J Med Genet A. 2020 Mar;182(3):536-542
pubmed: 31833209
Dis Model Mech. 2019 Nov 14;12(11):
pubmed: 31628096
Brain. 2012 Feb;135(Pt 2):469-82
pubmed: 22323514
Neuromuscul Disord. 2017 Mar;27(3):239-242
pubmed: 28109637
Orphanet J Rare Dis. 2019 Jul 16;14(1):179
pubmed: 31311558
Science. 2013 Aug 23;341(6148):896-9
pubmed: 23929950
Neuromuscul Disord. 2018 Jul;28(7):614-618
pubmed: 29910097
Skelet Muscle. 2018 Jul 30;8(1):23
pubmed: 30060766
Neuromuscul Disord. 2014 Apr;24(4):289-311
pubmed: 24581957

Auteurs

Luisa Paul (L)

Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Katrin Rupprich (K)

Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Adela Della Marina (A)

Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Anja Stein (A)

Department of General Pediatrics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Magdeldin Elgizouli (M)

Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Frank J Kaiser (FJ)

Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Bernd Schweiger (B)

Department of Radiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Angela Köninger (A)

Department of Obestetrics and Gynaecology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Antonella Iannaccone (A)

Department of Obestetrics and Gynaecology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Ute Hehr (U)

Center for Human Genetics, Regensburg, Germany / Department of Human Genetics, University of Regensburg, Regensburg, Germany.

Heike Kölbel (H)

Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Andreas Roos (A)

Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, K1H 8L1, Canada.

Ulrike Schara-Schmidt (U)

Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Alma Kuechler (A)

Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany. alma.kuechler@uk-essen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH